144
Views
8
CrossRef citations to date
0
Altmetric
EVALUATION OF RADIOCHEMOTHERAPY WITH LAROMUSTINE

Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors

, , , , , , , , & show all
Pages 277-285 | Received 18 Aug 2011, Accepted 02 Nov 2011, Published online: 20 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sara Rockwell, Tina A. Grove, Yanfeng Liu, Yung-Chi Cheng, Susan A. Higgins & Carmen J. Booth. (2013) Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy. International Journal of Radiation Biology 89:1, pages 16-25.
Read now

Articles from other publishers (7)

Hanim Saim, Siti N. M. Yassin, Maheza I. M. Salim, Khairunadwa Jemon, Rania H. AlAshwal, Asnida A. Wahab, Mariaulpa Sahalan, Hum Yan Chai & Lai K. Wee. (2022) Antitumor effect of infrared whole-body hyperthermia with curcumin in breast Cancer. Multimedia Tools and Applications 81:29, pages 41851-41868.
Crossref
Philip G. Penketh, Richard A. Finch, Rachel Sauro, Raymond P. Baumann, Elena S. Ratner & Krishnamurthy Shyam. (2018) pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs. Chemical Biology & Drug Design 91:1, pages 62-74.
Crossref
Krishnamurthy Shyam, Philip G. Penketh, Raymond P. Baumann, Rick A. Finch, Rui Zhu, Yong-Lian Zhu & Alan C. Sartorelli. (2015) Antitumor Sulfonylhydrazines: Design, Structure–Activity Relationships, Resistance Mechanisms, and Strategies for Improving Therapeutic Utility. Journal of Medicinal Chemistry 58:9, pages 3639-3671.
Crossref
Philip G. Penketh, Eric Patridge, Krishnamurthy Shyam, Raymond P. Baumann, Rui Zhu, Kimiko Ishiguro & Alan C. Sartorelli. (2014) Influence of Glutathione and Glutathione S -transferases on DNA Interstrand Cross-Link Formation by 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the Active Anticancer Moiety Generated by Laromustine . Chemical Research in Toxicology 27:8, pages 1440-1449.
Crossref
Philip G. Penketh, Krishnamurthy Shyam, Rui Zhu, Raymond P. Baumann, Kimiko Ishiguro & Alan C. Sartorelli. (2014) Influence of Phosphate and Phosphoesters on the Decomposition Pathway of 1,2-Bis(methylsulfonyl)-1-(2-chloroethyhydrazine (90CE), the Active Anticancer Moiety Generated by Laromustine, KS119, and KS119W. Chemical Research in Toxicology 27:5, pages 818-833.
Crossref
James E. HansenGrace ChanYanfeng LiuDenise C. HeganShibani DalalEloise DrayYoungho KwonYuanyuan XuXiaohua XuElizabeth Peterson-RothErik GeigerYilun LiuJoseph GeraJoann B. SweasyPatrick SungSara RockwellRobert N. NishimuraRichard H. WeisbartPeter M. Glazer. (2012) Targeting Cancer with a Lupus Autoantibody. Science Translational Medicine 4:157.
Crossref
Eugene Y. Kim, Yanfeng Liu, Oluwatoyin M. Akintujoye, Krishnamurthy Shyam, Tina A. Grove, Alan C. Sartorelli & Sara Rockwell. (2012) Preliminary Studies with a New Hypoxia-Selective Cytotoxin, KS119W, In Vitro and In Vivo . Radiation Research 178:3, pages 126-137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.